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ABSTRACT 
 
The Society for Endocrinology, Metabolism and Diabetes of South Africa (SEMDSA) 
estimates the prevalence of Type 2 Diabetes Mellitus in South Africa to be 
approximately 13% in the Indian, 3% in the European and 4.8-8% in the African 
population group. Morbidity from diabetes is a consequence of both macrovascular 
and microvascular disease. Over the last decade, a fundamental transformation of the 
principles of management of type 2 diabetes has occurred. This was driven by a large 
number of multicentre randomized clinical trials documenting improved outcomes 
associated not only with glycaemic control, but also with use of antihypertensive, 
lipid lowering and anti-platelet therapy. 
 
The objective of this research report was to ‘revisit’ our diabetes clinics to ascertain 
how many diabetic patients are reaching the lipid, blood pressure, body mass index, 
waist circumference and glucose targets as recommended by the SEMDSA guidelines 
and to ascertain if there has been any improvement since a previous study conducted a 
decade ago. 
 
Study design included a sample of 150 patients. Body mass indices (BMI), fasting 
lipograms, glycated haemoglobin (HbA1c), waist measurements and blood pressure 
were determined in patients with type 2 diabetes mellitus who were on oral agents or 
insulin (Protaphane), or a combination  thereof, and who were age 35 years or older. 
 
Results showed that, out of the 150 patients, 98 were females and 52 were males. 
Black patients constituted 68%, White 12,7%, Indian 10,7% and Coloured 8,7%. The 
mean age was 59 years. The mean HbA1c was 8,7% with HbA1c being more than 8% 
in 83 patients (55%). Obesity was present in 37,3% of the patients; it was class I  
(BMI 30-34,9 kg/m2) in 22%, class II (BMI 35-39,9) in 10% and class III (BMI >40) 
in 5,3%. Hypercholesterolaemia (total cholesterol > 5,0 mmol/l) was present in 
29,3%, hypertriglyceridaemia (total triglycerides > 1,5 mmol/l) in 45,3% of the 
patients. Waist circumference was greater or equal than 80cm in 98% of the females 
and greater or equal than 94cm in 69% of males. In the whole cohort of 150 patients, 
127 were hypertensive (84,67%). 78,74% of patients with hypertension had systolic 
blood pressure above or equal to 130 mmHg and 59,84% had diastolic blood pressure 
above or equal to 80 mmHg. Out of the 150 patients, 43% did not engage in regular 
exercise, 6% smoked cigarettes and 51% were on aspirin.  
 
In conclusion these findings are similar to those from a previous study conducted in 
1996 and show little improvement in the holistic care of patients with type 2 diabetes. 
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